Cite

HARVARD Citation

    Jonasova, A. et al. (n.d.). High level of full‐length cereblon mRNA in lower risk myelodysplastic syndrome with isolated 5q deletion is implicated in the efficacy of lenalidomide. European journal of haematology. pp. 27-34. [Online]. 
  
Back to record